BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21956473)

  • 1. Comments on the cross-talk of TGFβ and EGF in cancer.
    Jia M; Souchelnytstkyi S
    Exp Oncol; 2011 Sep; 33(3):170-3. PubMed ID: 21956473
    [No Abstract]   [Full Text] [Related]  

  • 2. Mammalian sterile-like 1 kinase inhibits TGFβ and EGF‑dependent regulation of invasiveness, migration and proliferation of HEC-1-A endometrial cancer cells.
    Attarha S; Andersson S; Mints M; Souchelnytskyi S
    Int J Oncol; 2014 Aug; 45(2):853-60. PubMed ID: 24841766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting TGFbeta-mediated processes in cancer.
    Romano MF
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):253-63. PubMed ID: 19333871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the antiproliferative effect of TGFbeta by EGF in primary human ovarian cancer cells.
    Dunfield LD; Nachtigal MW
    Oncogene; 2003 Jul; 22(30):4745-51. PubMed ID: 12879019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation.
    Tuli SS; Liu R; Chen C; Blalock TD; Goldstein M; Schultz GS
    Curr Eye Res; 2006 Sep; 31(9):709-19. PubMed ID: 16966143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing actions of TGFbeta and MAP kinase signaling in undifferentiated hen granulosa cells.
    Woods DC; Haugen MJ; Johnson AL
    Biochem Biophys Res Commun; 2005 Oct; 336(2):450-7. PubMed ID: 16139244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
    Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
    Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
    Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escaping from the TGFbeta anti-proliferative control.
    Seoane J
    Carcinogenesis; 2006 Nov; 27(11):2148-56. PubMed ID: 16698802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Involvement of cellular responses to growth factors in angiogenesis and transformation malignant].
    Sato Y; Matsuda T; Okamura K; Kuwano M
    Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1384-90. PubMed ID: 1714619
    [No Abstract]   [Full Text] [Related]  

  • 11. Cripto monoclonal antibodies.
    Hu XF; Xing PX
    Drug News Perspect; 2005 Jun; 18(5):293-303. PubMed ID: 16193101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin binding epidermal growth factor-like growth factor is a transforming growth factor beta-regulated gene in intestinal epithelial cells.
    Bulus N; Barnard JA
    Biochem Biophys Res Commun; 1999 Nov; 264(3):808-12. PubMed ID: 10544013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial and temporal patterns of expression of epidermal growth factor, transforming growth factor alpha and transforming growth factor beta 1-3 and their receptors in mouse jejunum after radiation treatment.
    Ruifrok AC; Mason KA; Lozano G; Thames HD
    Radiat Res; 1997 Jan; 147(1):1-12. PubMed ID: 8989363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor-sensitive molecular targets identified in primary and metastatic head and neck squamous cell carcinoma using microarray analysis.
    Miyazaki H; Patel V; Wang H; Ensley JF; Gutkind JS; Yeudall WA
    Oral Oncol; 2006 Mar; 42(3):240-56. PubMed ID: 16266819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy.
    Henson ES; Gibson SB
    Cell Signal; 2006 Dec; 18(12):2089-97. PubMed ID: 16815674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transforming growth factors and cancer].
    Zhu ZW; Li T; Wang YC
    Sheng Li Ke Xue Jin Zhan; 1996 Oct; 27(4):335-7. PubMed ID: 9772385
    [No Abstract]   [Full Text] [Related]  

  • 17. The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pre-gastrulation mouse embryo.
    Chen C; Ware SM; Sato A; Houston-Hawkins DE; Habas R; Matzuk MM; Shen MM; Brown CW
    Development; 2006 Jan; 133(2):319-29. PubMed ID: 16368929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Growth factors in human gastrointestinal carcinomas].
    Yasui W; Yoshida K; Tahara E
    Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1371-8. PubMed ID: 1651543
    [No Abstract]   [Full Text] [Related]  

  • 19. TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation.
    Docherty NG; O'Sullivan OE; Healy DA; Murphy M; O'neill AJ; Fitzpatrick JM; Watson RW
    Am J Physiol Renal Physiol; 2006 May; 290(5):F1202-12. PubMed ID: 16368739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelial cells.
    Lu Z; Lam KS; Wang N; Xu X; Cortes M; Andersen B
    Oncogene; 2006 May; 25(20):2920-30. PubMed ID: 16331278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.